Canavan disease may be classified as rare, but it is nonetheless devastating when you’re a parent who’s just been told your baby has it.  Yanhong Shi, Ph.D., director...

If everything goes as hoped, Victoria L. Seewaldt, M.D., may find a way to turn back the clock on cancer.   Seewaldt, City of Hope’s Ruth Ziegler Chair in Population Sciences...

A City of Hope investigational vaccine produced strong protective immunity against SARS-CoV-2, including neutralizing antibodies that recognize the current dominant circulating form, which is a mutant of the original Wuhan...

The remarkable results of a new City of Hope study show that the natural botanical Andrographis paniculata, when given in conjunction with chemotherapy, may be a major breakthrough in...

James Lacey Jr., Ph.D., M.P.H. Researchers looking to control the spread of COVID-19 are working with City of Hope scientists who manage a 25-year-old landmark study originally developed to track...

John J. Rossi, Ph.D. Two existing drugs, created by a City of Hope scientist using advanced genomic technology, are being tested for their potential to fight the COVID-19 epidemic. One could be used...

John Zaia, M.D. The California Institute for Regenerative Medicine (CIRM) awarded $750,000 to City of Hope’s John Zaia, M.D., for a clinical study on the use of blood plasma as a...

Don Diamond, Ph.D. As an institution dedicated to fighting cancer, diabetes and other life-threatening diseases, City of Hope is addressing the novel coronavirus threat on a number of fronts, including...

City of Hope’s Department of Stem Cell Biology and Regenerative Medicine has received a $4.9 million grant to train the next generation of scientific leaders in basic stem cell research and its translation into novel, lifesaving treatments...

Larry W. Kwak, M.D., Ph.D. As tens of thousands of new COVID-19 cases crop up each day worldwide and measures to slow its spread disrupt everyday life, the hopes of...